Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04684706 · ClinicalTrials.gov registry record · NA

Compressed Intermittent Theta Burst Stimulation

A NA study of Treatment-Resistant Depression, sponsored by University of Pennsylvania.

Active
Registry status
NA
Development phase
40
Enrollment target
2
Study locations

NCT04684706 is a NA study of Treatment-Resistant Depression that is active but no longer recruiting, run by University of Pennsylvania. The registered enrollment target is 40 participants, below the 373-participant average among 54 other Treatment-Resistant Depression trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04684706, a NA study of Treatment-Resistant Depression, is active but no longer recruiting, sponsored by University of Pennsylvania.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

In this proposal the investigators will use an accelerated TMS protocol that concentrates the magnetic stimulation that would usually occur over 6 weeks into 10 treatment sessions per days, for 5 consecutive days in patient with treatment-refractory depression. This protocol will build on a previously published study demonstrating clinical efficacy of intermittent theta-burst stimulation (iTBS) on left dorsolateral prefrontal cortex (L-dlPFC) in a treatment refractory population.

Interventions

  • DEVICE intermittent Theta Burst Stimulation

Study Locations (2)

California

  • Department of Interventional Psychiatry, University of California San Diego - La Jolla

Pennsylvania

  • Center for Neuromodulation in Depression and Stress - Philadelphia

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2020-02-20
Est. Completion 2027-01-20
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT04684706

The ClinicalTrials.gov registry entry for NCT04684706 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 373-participant average among 54 other Treatment-Resistant Depression trials with a reported enrollment target (89% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Treatment-Resistant Depression appearing as the primary indexed condition, and to 1 intervention - of which intermittent Theta Burst Stimulation is the first listed.

NCT04684706 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT04684706 about?

NCT04684706 is a clinical study titled "Compressed Intermittent Theta Burst Stimulation". In this proposal the investigators will use an accelerated TMS protocol that concentrates the magnetic stimulation that would usually occur over 6 weeks into 10 treatment sessions per days, for 5 consecutive days in patient with treatment-refractory depression. This protocol will build on a previous...

What is the current status of trial NCT04684706?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2020-02-20. Estimated completion is 2027-01-20.

What conditions does trial NCT04684706 study?

This clinical trial studies the following conditions: Treatment-Resistant Depression.

What interventions are being tested in trial NCT04684706?

The interventions under investigation include: intermittent Theta Burst Stimulation (DEVICE).

Who is sponsoring clinical trial NCT04684706?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04684706 being conducted?

This trial has 2 study locations across California, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Treatment-Resistant Depression

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.